Hygieia

• 02/05/2023
• Series B
• $22,000,000

Hygieia’s d-Nav® Insulin Management System includes an AI-powered application and helps people with Type 2 diabetes use insulin in a safe and effective way. It works by guiding users to adjust their insulin doses – based on changing blood glucose patterns -- every few days rather than three or four times annually. Studies show that some 90 percent of people using our d-Nav® service achieve lower A1c within three months. Patients tell us they feel better; experience fewer complications; spend less time at their physician’s office; and can lower their disease management costs. The d-Nav® insulin management system was developed by two University of Michigan researchers and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan.

---

---